Katherine V. Stultz - 25 Jun 2024 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRON	Stock Option (Right to Buy)	Award	$0	+34,000		$0.000000	34,000	25 Jun 2024	Common Stock	34,000	$0.9500	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.